These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6410039)

  • 21. Effects of some hypolipidemic agents on biochemical values and hepatic peroxisomal enzymes in rats: comparison of probucol, CGA, KCD-232, MLM-160, AL-369 and clinofibrate with clofibrate.
    Watanabe T; Mitsukawa M; Horie S; Suga T; Seki K
    J Pharmacobiodyn; 1987 Mar; 10(3):142-7. PubMed ID: 3625448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-hyperlipidemic effect of iodine eggs: studies on the mechanism of its action].
    Kaji K; Miyashita M; Seyama Y; Yamashita S
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):451-7. PubMed ID: 6469134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of peroxisomal fatty acyl-CoA beta-oxidation in phospholipid biosynthesis.
    Hayashi H; Takahata S
    Arch Biochem Biophys; 1991 Feb; 284(2):326-31. PubMed ID: 1989516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of clofibrate on lipids and fatty acids of mouse liver.
    Pennacchiotti GL; Rotstein NP; Aveldaño MI
    Lipids; 1996 Feb; 31(2):179-85. PubMed ID: 8835406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat.
    Berman JS; Hiley CR; Wilson AC
    Br J Pharmacol; 1983 Mar; 78(3):533-41. PubMed ID: 6839062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate.
    Foliot A; Touchard D; Mallet L
    Biochem Pharmacol; 1986 May; 35(10):1685-90. PubMed ID: 3707598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal responses to clofibrate in ketogenesis and triglyceride and cholesterol secretion in isolated rat liver.
    Ide T; Oku H; Sugano M
    Metabolism; 1982 Oct; 31(10):1065-72. PubMed ID: 7132732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
    Rousselet F; Fredj G; Clenet M
    Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats. II. Comparative action of clofibrate and tiadenol on biliary and fecal excretion of cholesterol and its metabolites in rats].
    Fredj G; Clenet M; Rousselet F
    Ann Pharm Fr; 1986; 44(5):347-54. PubMed ID: 3579157
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of colestipol hydrochloride on cholesterol and bile acids absorption in the rat intestinal tract.
    Fujihashi T; Munekiyo K; Meshi T
    J Pharmacobiodyn; 1981 Aug; 4(8):552-8. PubMed ID: 7299619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
    Redinger RN; Passi RB
    Can J Physiol Pharmacol; 1979 Mar; 57(3):235-41. PubMed ID: 109175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Triglyceride synthesis and oleic acid catabolism by hepatic microsomes and mitochondria in clofibrate or procetofen-treated rats].
    Clouet E; Paris R
    Reprod Nutr Dev (1980); 1980; 20(3A):637-45. PubMed ID: 7349434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypolipidemic Effect of a Blue-Green Alga (Nostoc commune) Is Attributed to Its Nonlipid Fraction by Decreasing Intestinal Cholesterol Absorption in C57BL/6J Mice.
    Ku CS; Kim B; Pham TX; Yang Y; Weller CL; Carr TP; Park YK; Lee JY
    J Med Food; 2015 Nov; 18(11):1214-22. PubMed ID: 26161942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia.
    Takeuchi N; Kukita H; Kajiyama G; Fujiyama M; Ishikawa K; Miki H; Mishima T; Murata K; Asano T
    Atherosclerosis; 1982 Apr; 42(2-3):129-39. PubMed ID: 7073798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
    Seki K; Fukuda M; Isegawa J; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of clofibrate on cholesterol metabolism.
    Kudchodkar BJ; Sodhi HS; Horlick DL; Mason DT
    Clin Pharmacol Ther; 1977 Aug; 22(2):154-63. PubMed ID: 884917
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
    Pertsemlidis D; Panveliwalla D; Ahrens EH
    Gastroenterology; 1974 Apr; 66(4):565-73. PubMed ID: 4821079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic effect of ethyl all-cis-5,8,11,14,17-eicosapentaenoate (EPA-E) in rats.
    Mizuguchi K; Yano T; Kojima M; Tanaka Y; Ishibashi M; Masada A; Sato M; Mizota M; Fukutake K; Saito Y
    Jpn J Pharmacol; 1992 Jul; 59(3):307-12. PubMed ID: 1434127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.